Product Description
Product Name: Baricitinib Tablets
Strength: 4 mg
Form: Oral Tablet
Category: Janus Kinase (JAK) Inhibitor / Immunomodulator
Indication: Moderate to Severe Rheumatoid Arthritis
Baricitinib 4 mg Tablets are an advanced oral treatment for moderate to severe rheumatoid arthritis in adults who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs). Baricitinib is a selective Janus kinase (JAK) inhibitor that works by modulating the immune response to reduce joint pain, swelling, and stiffness, while also slowing the progression of bone and joint damage.
